Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05672953 · ClinicalTrials.gov registry record
Biogeography of the Oral Microbiome
A clinical trial of Oral Microbiome, sponsored by Viome.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05672953: Completed study of Oral Microbiome, sponsored by Viome.
NCT05672953 is a study of Oral Microbiome that has completed, run by Viome. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05672953, a study of Oral Microbiome, has completed, sponsored by Viome.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
A cross-sectional study to metatranscriptomically analyze and compare the oral microbiome in different environmental niches within the oral cavity.
Primary Outcome
Number of species present in different areas swabbed in the oral cavity.
Conditions Studied
Study Locations (1)
Washington
- Viome Life Sciences - Bothell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-05-20 |
| Est. Completion | 2021-08-10 |
What the finished NCT05672953 record still lists
NCT05672953 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Oral Microbiome appearing as the primary indexed condition, and to 0 interventions.
NCT05672953 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05672953 about?
NCT05672953 is a clinical study titled "Biogeography of the Oral Microbiome". A cross-sectional study to metatranscriptomically analyze and compare the oral microbiome in different environmental niches within the oral cavity.
What is the current status of trial NCT05672953?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-05-20. Estimated completion is 2021-08-10.
What conditions does trial NCT05672953 study?
This clinical trial studies the following conditions: Oral Microbiome.
Who is sponsoring clinical trial NCT05672953?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05672953 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI